Unknown

Dataset Information

0

Fulminant Marginal Keratitis Induced by Atezolizumab, a Programmed Death Ligand 1 Inhibitor for Lung Cancer

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10697742 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.
| S-EPMC5993485 | biostudies-literature
Unknown Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer.
| S-EPMC4700219 | biostudies-literature
Unknown Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma.
| S-EPMC6926111 | biostudies-literature
Unknown Chemotherapy and programmed cell death protein 1/programmed death-ligand 1 inhibitor combinations for tyrosine kinase inhibitor-resistant, epidermal growth factor receptor-mutated non-small-cell lung cancer: a meta-analysis.
| S-EPMC11381989 | biostudies-literature
Unknown The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
| S-EPMC6542636 | biostudies-literature
Unknown Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
| S-EPMC7947423 | biostudies-literature
Unknown Programmed death ligand-1 expression in non-small cell lung cancer.
| S-EPMC6125250 | biostudies-literature
Unknown Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.
| S-EPMC10011508 | biostudies-literature
Unknown Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer.
| S-EPMC4854782 | biostudies-literature
Unknown Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer.
| S-EPMC9250021 | biostudies-literature